4d pharma (4d pharma) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Dec. 2021)

View and export this data going back to 2021. Start your Free Trial

What is 4d pharma Change In Payables And Accrued Expense?

4d pharma's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2021 was $0.00 Mil. It means 4d pharma's Accounts Payable & Accrued Expense stayed the same from Jun. 2021 to Dec. 2021 .

4d pharma's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2021 was $0.00 Mil. It means 4d pharma's Accounts Payable & Accrued Expense stayed the same from Dec. 2020 to Dec. 2021 .

4d pharma Change In Payables And Accrued Expense Historical Data

The historical data trend for 4d pharma's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Change In Payables And Accrued Expense Chart

4d pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

4d pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Change In Payables And Accrued Expense	Get a 7-Day Free Trial											-	-	-	-	-

4d pharma Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

4d pharma Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of 4d pharma's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

4d pharma (4d pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ

Website

https://www.4dpharmaplc.com

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.